"The Prix Galien honors outstanding achievement in two areas that are critical to human health: science and innovation"

- Tedros Adhanom Ghebreyesus, Director-General, World Health Organization

"The Prix Galien is a welcome initiative to stimulate creative research and promote excellence."

-Barack Obama, President, United States (2008)

“The Galien Foundation brings together the top scientists in the world. You have Nobel Laureates across the spectrum of scientific disciplines meeting and talking with members of the pharmaceutical industry to see what’s going on at the cutting edge, because ultimately that’s going to benefit patients.”

— William Hait, MD, PhD, Global Head of Research & Development, Janssen, Pharmaceutical Companies of Johnson & Johnson

“It is essential that we support innovative research efforts to develop new treatments and advance the study of medicine….I applaud all those in attendance [at the Prix Galien USA Awards Ceremony] as we continue to forge a path to a brighter and healthier future for all.”

— Bill de Blasio, Mayor, New York City

"The Prix Galien USA recognizes the important research necessary to develop innovative medicines and devices that have a lifesaving impact on individuals and families across the globe."

-Kathleen Sebelius, Secretary of Health and Human Services, United States (2011)

“The Prix Galien USA] is a snapshot of the important work that The Galien Foundation does throughout the year, bringing organizations together to drive progress – an effort that resonates deeply with the Academy…”

— Ellis Rubinstein, President and CEO, The New York Academy of Sciences

“The Prix Galien USA process reinforces optimism about future impact of pharma innovation on health. The future will bring better products and a better process. More companies will be collaborating with each other and across sectors, and importantly, with patients. Medical research is a team sport. But the final common pathway still requires great chemistry married to great biology.”

— Michael Rosenblatt, MD, Chief Medical Officer, Flagship Ventures

“The Annual Prix Galien Awards Competition] honors those in the pharmaceutical industry who have developed the technical, scientific and clinical research skills necessary to develop innovative medicines and devices. Your work is invaluable.”

— Margaret Hamburg, Former Commissioner. U.S. Food and Drugs Administration (2011)

“The Galien Forum is wonderfully organized and always well-received.”

— David Felquate, MD, PhD, Vice President, Immuno-Oncology Development, Bristol-Myers Squibb

“The Prix Galien recognizes men and women from the pharmaceutical and biomedical industries whose contributions of science have improved and saved countless lives. I commend the Galien Foundation for its leadership in this vital field.”

-Michael Bloomberg, Mayor, New York City

“The Galien Foundation has played an important role in the health and medical technology industry.”

— Cato T. Laurencin, MD, PhD, Van Dusen Distinguished Endowed Professor of Orthopedic Surgery, Professor of Chemical and Biomolecular Engineering, Professor of Materials Science and Engineering, and Professor of Biomedical Engineering, University of Connecticut

[To Dr. Roy Vagelos] “Rosalynn joins me in congratulating you on receiving the 2007 Galien Pro Bono Humanum Prize at the Prix Galien Awards Ceremony.”

-Jimmy Carter, Former President, United States & Founder, Carter Center (2007)

[The Galien Forum] “is about bringing the crème de la crème of industry and science to engage and discuss some of the most important issues of our time.”

— Sachin Jain, MD, MBA, Chief Medical Information and Innovation Officer, Merck & Co.

“I appreciate the dedication, vision and leadership of the Prix Galien USA in improving the health of people around the world.”

— Mace Rothenberg, MD, Chief Development Officer, Oncology, Pfizer Global Product Development

“Our Prix Galien USA awards [for Cosentyx and Gleevec] …represent years of hard work by our scientists. These wins underscore our commitment to addressing the unmet medical needs of patients through science-based innovation.”

— Joseph Jimenez, CEO, Novartis

"I am particularly grateful to receive this award on behalf of all the people who work in our Foundation."

-Bill Clinton, Former President, United States (2010)

"I applaud Prix Galien for recognizing the pioneering spirit of American innovation and research."

-John McCain, United States Senator (2008)

“The Galien Forum convenes an impressive group of highly engaged people.”

— David Epstein, MBA, Former CEO & Division Head, Novartis Pharmaceuticals

The Prix Galien is a very special award that honors the pharmaceutical, biotechnology and medical technology industries for landmark achievements. It honors excellence in the pursuit of science that cannot be recognized individually. The special feature of the Pro Bono Humanum Award adds to the uniqueness of these awards.”

— Bengt Samuelsson, Biochemist, Nobel Prize winner

"The Prix Galien is the right event, on the right issue at the right time. I thank the Galien Foundation for bringing us together and for recognizing that a healthier world is a safer world and a more just world."

— Ban Ki-moon, Secretary-General, United Nations (2010)

"We recognize the importance of the Prix Galien in promoting drug research, and we salute the excellent work of the Jury."

— Philippe Douste-Blazy, Former Minister of Foreign Affairs, France (2006)

"It is a pleasure to congratulate all those who promote the Prix Galien and pharmaceutical research: they play a vital role in the fight against disease throughout the world."

— John Major, Former Prime Minister, United Kingdom (1996)

"The Prix Galien is a prestigious award, a magnificent occasion to pay recognition to our researchers and to encourage our industry."

— Jean Chretien, Former Prime Minister, Canada (1994)